HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Simone Selected Research

Breast Neoplasms (Breast Cancer)

4/2018Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma.
11/2017Comment on 'Renewed interest in the progesterone receptor in breast cancer'.
11/2017VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.
9/2017NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.
10/2016Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer.
5/2016Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
1/2016Expression of proteins involved in DNA damage response in familial and sporadic breast cancer patients.
9/2014CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen.
11/2013Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.
4/2013Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Simone Research Topics

Disease

29Neoplasms (Cancer)
04/2018 - 09/2006
19Breast Neoplasms (Breast Cancer)
04/2018 - 09/2002
9Neoplasm Metastasis (Metastasis)
01/2018 - 06/2012
6Colorectal Neoplasms (Colorectal Cancer)
10/2016 - 09/2010
5Hypoxia (Hypoxemia)
01/2016 - 11/2011
4Stomach Neoplasms (Stomach Cancer)
01/2018 - 09/2006
4Colonic Neoplasms (Colon Cancer)
01/2018 - 02/2013
3Carcinogenesis
01/2018 - 01/2008
3Circulating Neoplastic Cells
11/2014 - 02/2013
3Infections
07/2012 - 01/2006
2Lymphatic Metastasis
01/2017 - 06/2012
2Adenocarcinoma of Lung
02/2016 - 09/2015
2Lung Neoplasms (Lung Cancer)
02/2016 - 07/2013
2Familial Breast Cancer
06/2013 - 01/2013
2Hepatocellular Carcinoma (Hepatoma)
07/2012 - 01/2008
2Virus Diseases (Viral Diseases)
07/2012 - 01/2008
1Melanoma (Melanoma, Malignant)
01/2018
1Thyroid Neoplasms (Thyroid Cancer)
01/2017
1Anaplastic Thyroid Carcinoma
01/2017
1Triple Negative Breast Neoplasms
10/2016
1Uterine Neoplasms (Uterine Cancer)
02/2016
1Chromosomal Instability (Chromosome Stability)
02/2015
1Genomic Instability
02/2015
1Residual Neoplasm
11/2014
1Retinoblastoma (Glioblastoma, Retinal)
01/2014
1Adenocarcinoma
01/2014
1Disease Progression
12/2013
1Lymphoma (Lymphomas)
12/2013
1Carcinoma (Carcinomatosis)
04/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2010
1Ductal Carcinoma
07/2009

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2009
7Biological ProductsIBA
11/2016 - 09/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 09/2006
6Biomarkers (Surrogate Marker)IBA
11/2017 - 11/2011
6DNA (Deoxyribonucleic Acid)IBA
07/2013 - 01/2006
4Progesterone Receptors (Progesterone Receptor)IBA
11/2017 - 09/2012
4Estrogen ReceptorsIBA
09/2015 - 01/2007
3Tryptases (Tryptase)IBA
04/2018 - 06/2011
3sodium-hydrogen exchanger regulatory factorIBA
09/2017 - 11/2011
3Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2017 - 01/2015
3human ERBB2 proteinIBA
11/2016 - 11/2011
3MicroRNAs (MicroRNA)IBA
01/2016 - 06/2013
3Capecitabine (Xeloda)FDA Link
01/2016 - 11/2013
3Sodium-Hydrogen ExchangersIBA
06/2015 - 06/2011
3ParaffinIBA
01/2015 - 09/2002
3Plasminogen Activator Inhibitor 1IBA
11/2014 - 01/2008
3Hormones (Hormone)IBA
01/2013 - 03/2012
2CateninsIBA
10/2017 - 10/2016
2Estrogens (Estrogen)FDA Link
10/2016 - 11/2013
2Epirubicin (Ellence)FDA LinkGeneric
01/2016 - 01/2015
2ErbB Receptors (EGF Receptor)IBA
09/2015 - 09/2010
2Tyrosine Kinase InhibitorsIBA
09/2015 - 09/2010
2Formaldehyde (Formol)FDA Link
01/2015 - 09/2002
2AntigensIBA
04/2013 - 07/2012
2Monoclonal AntibodiesIBA
04/2013 - 09/2010
2Plasminogen Activators (Plasminogen Activator)IBA
07/2012 - 01/2008
2Tumor Biomarkers (Tumor Markers)IBA
03/2012 - 07/2009
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
11/2011 - 09/2006
2Telomerase (Telomerase Reverse Transcriptase)IBA
07/2009 - 01/2008
1Transcription Factors (Transcription Factor)IBA
04/2018
1Wnt ReceptorsIBA
01/2018
1Pharmaceutical PreparationsIBA
08/2017
1AntioxidantsIBA
08/2017
1Adenosine Monophosphate (AMP)IBA
01/2017
1ThyroglobulinFDA Link
01/2017
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2016
1ProgesteroneFDA LinkGeneric
10/2016
1Poly (ADP-Ribose) Polymerase-1IBA
05/2016
1Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2016
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
05/2016
1Adenosine Diphosphate (ADP)IBA
05/2016
1BRCA1 ProteinIBA
05/2016
1CrizotinibIBA
02/2016
1Anaplastic Lymphoma KinaseIBA
02/2016
1Codon (Codons)IBA
09/2015
1Indicators and Reagents (Reagents)IBA
02/2015
1Environmental BiomarkersIBA
11/2014
1Transforming Growth Factor beta (TGF-beta)IBA
11/2014
1CytokinesIBA
11/2014
1Thymidylate SynthaseIBA
09/2014
1Irinotecan (Camptosar)FDA LinkGeneric
09/2014
1trioctyl phosphine oxide (TOPO)IBA
09/2014
1Type I DNA Topoisomerases (Topoisomerase I)IBA
09/2014
1Cyclin-Dependent Kinase Inhibitor p16IBA
01/2014
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2014
1Trastuzumab (Herceptin)FDA Link
11/2013
1Lapatinib (GW572016)FDA Link
11/2013
1PAR-2 ReceptorIBA
08/2013
1Peptide Hydrolases (Proteases)FDA Link
08/2013
1RNA (Ribonucleic Acid)IBA
07/2013
1Epidermal Growth Factor (EGF)IBA
04/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
04/2013
1CXC ChemokinesIBA
04/2013
1Keratin-7 (Cytokeratin 7)IBA
04/2013
1Phenobarbital (Luminal)FDA Link
09/2012
1Cell-Free Nucleic AcidsIBA
07/2009

Therapy/Procedure

10Therapeutics
01/2018 - 09/2012
3Drug Therapy (Chemotherapy)
02/2016 - 01/2015
2Adjuvant Chemotherapy
09/2015 - 11/2013